247 related articles for article (PubMed ID: 28780618)
1. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
Sun M; Yang P; Yang Y; Ye J
Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
3. CD4⁺ T cells from behcet patients produce high levels of IL-17.
Chi W; Zhou S; Yang P; Chen L
Eye Sci; 2011 Jun; 26(2):65-9. PubMed ID: 21692201
[TBL] [Abstract][Full Text] [Related]
4. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
6. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
10. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
Liu X; Yang P; Wang C; Li F; Kijlstra A
Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
[TBL] [Abstract][Full Text] [Related]
11. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X
Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866
[TBL] [Abstract][Full Text] [Related]
12. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
13. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
15. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 Receptor-Associated Kinase 1/4 as a Novel Target for Inhibiting Neointimal Formation After Carotid Balloon Injury.
Bai S; Li D; Zhou Z; Cao J; Xu T; Zhang X; Wang Y; Guo J; Zhang Y
J Atheroscler Thromb; 2015; 22(12):1317-37. PubMed ID: 26310493
[TBL] [Abstract][Full Text] [Related]
17. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
18. T-bet expression is upregulated in active Behçet's disease.
Li B; Yang P; Zhou H; Zhang Z; Xie C; Lin X; Huang X; Kijlstra A
Br J Ophthalmol; 2003 Oct; 87(10):1264-7. PubMed ID: 14507763
[TBL] [Abstract][Full Text] [Related]
19. Berberine exerts an anti-inflammatory role in ocular Behcet's disease.
Yang Y; Wang Q; Xie M; Liu P; Qi X; Liu X; Li Z
Mol Med Rep; 2017 Jan; 15(1):97-102. PubMed ID: 27922688
[TBL] [Abstract][Full Text] [Related]
20. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]